Drug · DIN 02525542 · Radiopharmaceutical
NETVISION
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since January 1, 2025; first marketed May 3, 2023.
- Drug Identification Number (DIN)
- 02525542
- Company (DIN owner)
- University Health NetworkToronto, Ontario, Canada
- Schedule
- Schedule c
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Other diagnostic radiopharm. for tumor detection V09IX
- Class
- Radiopharmaceutical
- Record last updated
- February 3, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GALLIUM 68 Ga OXODOTREOTIDE | 122 MBq | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 21, 2023: NOC 30385New Drug Submission (NDS) · Administrative ¿ Change in Product Ownership
- February 24, 2022: NOC 27664New Drug Submission (NDS)